[STI 571 for treating 19 patients with chronic-phase chronic myeloid leukemia]. (Record no. 14361866)

MARC details
000 -LEADER
fixed length control field 01426 a2200409 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250514162453.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200403s 0 0 chi d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1000-2588
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Meng, Fan-yi
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20040331
245 00 - TITLE STATEMENT
Title [STI 571 for treating 19 patients with chronic-phase chronic myeloid leukemia].
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA
Date of publication, distribution, etc. Nov 2003
300 ## - PHYSICAL DESCRIPTION
Extent 1149-50 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: English Abstract; Journal Article; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adolescent
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Benzamides
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Follow-Up Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Imatinib Mesylate
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Leukemia, Myelogenous, Chronic, BCR-ABL Positive
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Leukemia, Myeloid, Chronic-Phase
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Piperazines
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Pyrimidines
General subdivision adverse effects
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Zheng, Wei-yang
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Liu, Xiao-li
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Xu, Bing
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Song, Lan-lin
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Zhang, Yu
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Huang, Fen
773 0# - HOST ITEM ENTRY
Title Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA
Related parts vol. 23
-- no. 11
-- p. 1149-50

No items available.